Led by Strategy, Scientifically Setting Medium and Long-term ESG Goals

In recent years, JiuZhou Pharma has actively integrated sustainable development into its corporate governance system. The company has established clear medium and long-term ESG development goals around three key areas: environmental protection, social responsibility, and corporate governance. For example, in the environmental domain, the company is committed to reducing greenhouse gas emissions per unit of revenue by 25% by 2030 compared to 2023, and increasing the share of renewable energy usage to over 50%. In terms of social responsibility, the company plans to have 80% of key suppliers sign social and environmental clauses, with employee training coverage reaching no less than 95%. On the governance front, JiuZhou Pharma is advancing board diversification and aims to achieve a business ethics training coverage rate of over 95%.

These goals are based on the company's operational characteristics and industry trends, referencing international standards such as GRI and SASB. Combined with greenhouse gas accounting and supply chain management outcomes, the goals were formulated under the leadership of the Board’s Strategic Decision-Making Committee, ensuring that they are scientific, measurable, and actionable.

Building a Data Governance System to Support Continuous ESG Performance Improvement

To support the achievement of these goals, JiuZhou Pharma has continuously strengthened its ESG data management system, driving the transformation of sustainability from concept to tangible results. The company has built an ESG database that covers multiple dimensions, including the environment, health and safety, energy, compliance, employees, and supply chain. By adopting a unified approach, systematized data collection, and process monitoring, the company enhances the accuracy and traceability of its data. Additionally, JiuZhou Pharma has been optimizing the data reporting process, encouraging shared responsibility across subsidiaries, factories, and functional departments, and establishing an efficient "headquarters coordination—department collaboration—business implementation" working mechanism.

Based on data insights, the company evaluates key ESG performance indicators (KPIs) quarterly and discloses the progress of each indicator in its annual ESG report. This enables transparent external communication and continuous internal improvement. In 2023, the company first incorporated carbon emission data into its financial analysis, providing quantitative support for green decision-making.

This award not only acknowledges the company's past efforts but will also inspire JiuZhou Pharma to further solidify its ESG strategy. In the future, the company will continue to refine its ESG goal system, deepen its data governance capabilities, and actively promote the integration of dual-carbon strategies, green supply chains, and responsible governance into its business. JiuZhou Pharma aims to build a healthy and sustainable future together with stakeholders.

About BSI

The British Standards Institution (BSI) is a century-old organization, granted Royal Charter in the UK, that participates in the development and publication of numerous internationally recognized standards. As the UK's national standards body, BSI is renowned globally for its annual compilation of over 2,000 standards. Additionally, as one of the founding members of the International Organization for Standardization (ISO), BSI played a key role in establishing the globally trusted and widely recognized ISO series of management systems.

Led by Strategy, Scientifically Setting Medium and Long-term ESG Goals

In recent years, JiuZhou Pharma has actively integrated sustainable development into its corporate governance system. The company has established clear medium and long-term ESG development goals around three key areas: environmental protection, social responsibility, and corporate governance. For example, in the environmental domain, the company is committed to reducing greenhouse gas emissions per unit of revenue by 25% by 2030 compared to 2023, and increasing the share of renewable energy usage to over 50%. In terms of social responsibility, the company plans to have 80% of key suppliers sign social and environmental clauses, with employee training coverage reaching no less than 95%. On the governance front, JiuZhou Pharma is advancing board diversification and aims to achieve a business ethics training coverage rate of over 95%.

These goals are based on the company's operational characteristics and industry trends, referencing international standards such as GRI and SASB. Combined with greenhouse gas accounting and supply chain management outcomes, the goals were formulated under the leadership of the Board’s Strategic Decision-Making Committee, ensuring that they are scientific, measurable, and actionable.

Building a Data Governance System to Support Continuous ESG Performance Improvement

To support the achievement of these goals, JiuZhou Pharma has continuously strengthened its ESG data management system, driving the transformation of sustainability from concept to tangible results. The company has built an ESG database that covers multiple dimensions, including the environment, health and safety, energy, compliance, employees, and supply chain. By adopting a unified approach, systematized data collection, and process monitoring, the company enhances the accuracy and traceability of its data. Additionally, JiuZhou Pharma has been optimizing the data reporting process, encouraging shared responsibility across subsidiaries, factories, and functional departments, and establishing an efficient "headquarters coordination—department collaboration—business implementation" working mechanism.

Based on data insights, the company evaluates key ESG performance indicators (KPIs) quarterly and discloses the progress of each indicator in its annual ESG report. This enables transparent external communication and continuous internal improvement. In 2023, the company first incorporated carbon emission data into its financial analysis, providing quantitative support for green decision-making.

This award not only acknowledges the company's past efforts but will also inspire JiuZhou Pharma to further solidify its ESG strategy. In the future, the company will continue to refine its ESG goal system, deepen its data governance capabilities, and actively promote the integration of dual-carbon strategies, green supply chains, and responsible governance into its business. JiuZhou Pharma aims to build a healthy and sustainable future together with stakeholders.

About BSI

The British Standards Institution (BSI) is a century-old organization, granted Royal Charter in the UK, that participates in the development and publication of numerous internationally recognized standards. As the UK's national standards body, BSI is renowned globally for its annual compilation of over 2,000 standards. Additionally, as one of the founding members of the International Organization for Standardization (ISO), BSI played a key role in establishing the globally trusted and widely recognized ISO series of management systems.

Led by Strategy, Scientifically Setting Medium and Long-term ESG Goals

In recent years, JiuZhou Pharma has actively integrated sustainable development into its corporate governance system. The company has established clear medium and long-term ESG development goals around three key areas: environmental protection, social responsibility, and corporate governance. For example, in the environmental domain, the company is committed to reducing greenhouse gas emissions per unit of revenue by 25% by 2030 compared to 2023, and increasing the share of renewable energy usage to over 50%. In terms of social responsibility, the company plans to have 80% of key suppliers sign social and environmental clauses, with employee training coverage reaching no less than 95%. On the governance front, JiuZhou Pharma is advancing board diversification and aims to achieve a business ethics training coverage rate of over 95%.

These goals are based on the company's operational characteristics and industry trends, referencing international standards such as GRI and SASB. Combined with greenhouse gas accounting and supply chain management outcomes, the goals were formulated under the leadership of the Board’s Strategic Decision-Making Committee, ensuring that they are scientific, measurable, and actionable.

Building a Data Governance System to Support Continuous ESG Performance Improvement

To support the achievement of these goals, JiuZhou Pharma has continuously strengthened its ESG data management system, driving the transformation of sustainability from concept to tangible results. The company has built an ESG database that covers multiple dimensions, including the environment, health and safety, energy, compliance, employees, and supply chain. By adopting a unified approach, systematized data collection, and process monitoring, the company enhances the accuracy and traceability of its data. Additionally, JiuZhou Pharma has been optimizing the data reporting process, encouraging shared responsibility across subsidiaries, factories, and functional departments, and establishing an efficient "headquarters coordination—department collaboration—business implementation" working mechanism.

Based on data insights, the company evaluates key ESG performance indicators (KPIs) quarterly and discloses the progress of each indicator in its annual ESG report. This enables transparent external communication and continuous internal improvement. In 2023, the company first incorporated carbon emission data into its financial analysis, providing quantitative support for green decision-making.

This award not only acknowledges the company's past efforts but will also inspire JiuZhou Pharma to further solidify its ESG strategy. In the future, the company will continue to refine its ESG goal system, deepen its data governance capabilities, and actively promote the integration of dual-carbon strategies, green supply chains, and responsible governance into its business. JiuZhou Pharma aims to build a healthy and sustainable future together with stakeholders.

About BSI

The British Standards Institution (BSI) is a century-old organization, granted Royal Charter in the UK, that participates in the development and publication of numerous internationally recognized standards. As the UK's national standards body, BSI is renowned globally for its annual compilation of over 2,000 standards. Additionally, as one of the founding members of the International Organization for Standardization (ISO), BSI played a key role in establishing the globally trusted and widely recognized ISO series of management systems.